drugset / Trial / NCT01417026
Intranasal Oxytocin and Learning in Autism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of this study is to determine the safety and therapeutic potential of intranasal oxytocin in children and adolescents with autism spectrum disorder (ASD) when paired with a computer game intervention that is designed to enhance face perception skills.
Timeline
- Start
- 2011-09
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxytocin | Peptide | 24 iu | Intranasal |